Hepatitis B, Hepatitis C, and HIV Seroprevalence and Their Association with Dialysis Adequacy and Glycaemic Parameters in Haemodialysis Patients: A Cross-Sectional Study from Somalia
Open Access
- 1 August 2026
- journal article
- research article
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 19, 1-9
Abstract
Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections disproportionately affect haemodialysis (HD) patients in sub-Saharan Africa, yet Somali data remain scarce. We aimed to determine HBsAg, anti-HCV, and anti-HIV seroprevalence among HD patients in Mogadishu and to identify independent predictors of HBsAg seropositivity among measures of dialysis adequacy and glycaemic parameters. Methods: Single-centre retrospective cross-sectional study of 599 HD patients in Mogadishu, Somalia (June 2024–February 2026). Urea reduction ratio (URR) was calculated from pre- and post-dialysis urea. Bivariable comparisons used Mann–Whitney U, Fisher exact, and chi-square tests. Multivariable logistic regression assessed independent predictors of HBsAg positivity, adjusting for age, sex, fasting glucose, URR, and pre-dialysis creatinine (n=569 complete cases). Results: HBsAg positivity was 5.5% (33/599) and anti-HCV 2.3% (14/599); no patient was HIV-positive. HBsAg-positive patients were older, more frequently male, and had higher pre-dialysis urea, creatinine, URR, and fasting glucose (all p< 0.05), with equivalent post-dialysis clearance; HbA1c, AST, and ALT did not differ. Anti-HBs titres were near-absent in HBsAg-positive patients (0.3 vs 26.3 IU/L; p< 0.001). On multivariable analysis, older age (OR 1.023), male sex (OR 2.457), and higher URR (OR 1.031) independently predicted HBsAg positivity (AUROC 0.753); fasting glucose and creatinine were not independent after adjustment. With an events-per-variable ratio of 6.2, these findings are hypothesis-generating. Conclusion: Age, male sex, and URR not glycaemic or hepatic parameters independently predicted HBsAg positivity in this cohort. Near-absent anti-HBs titres indicate a critical vaccination gap, supporting universal hepatitis B screening, high-dose vaccination before dialysis initiation, and enhanced infection control in resource-limited settings.Keywords
This publication has 18 references indexed in Scilit:
- Hepatitis B Vaccination in Advanced Chronic Kidney Disease: A Quality Improvement Project at a Veteran Affairs Chronic Kidney Disease ClinicInfectious Disease Reports, 2021
- Prevalence and Risk Factors Associated with Hepatitis B and Hepatitis C Infections among Patients Undergoing Hemodialysis: A Single-Centre Study in SomaliaInternational Journal of Nephrology, 2021
- The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysisPLOS ONE, 2021
- Predicting related factors of immunological response to hepatitis B vaccine in hemodialysis patients based on integration of decision tree classification and logistic regressionHuman Vaccines & Immunotherapeutics, 2021
- Adequacy of Hemodialysis and Its Associated Factors among Patients Undergoing Chronic Hemodialysis in Dar es Salaam, TanzaniaInternational Journal of Nephrology, 2020
- Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targetsThe Lancet Gastroenterology & Hepatology, 2017
- Serological and molecular analysis on the relationships between type 2 diabetes mellitus and hepatitis B virus infectionThe Journal of Infection in Developing Countries, 2016
- Hepatitis B Virus X Protein Impairs Hepatic Insulin Signaling Through Degradation of IRS1 and Induction of SOCS3PLOS ONE, 2010
- Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006American Journal of Kidney Diseases, 2006
- Effect of Dialysis Dose and Membrane Flux in Maintenance HemodialysisNew England Journal of Medicine, 2002